BR112023019228A2 - Peptídeo e composição contendo o peptídeo - Google Patents

Peptídeo e composição contendo o peptídeo

Info

Publication number
BR112023019228A2
BR112023019228A2 BR112023019228A BR112023019228A BR112023019228A2 BR 112023019228 A2 BR112023019228 A2 BR 112023019228A2 BR 112023019228 A BR112023019228 A BR 112023019228A BR 112023019228 A BR112023019228 A BR 112023019228A BR 112023019228 A2 BR112023019228 A2 BR 112023019228A2
Authority
BR
Brazil
Prior art keywords
peptide
amino acid
composition containing
acid sequence
cha
Prior art date
Application number
BR112023019228A
Other languages
English (en)
Inventor
Haruaki Kurasaki
Hidetomo Kitamura
Hirofumi Ohashi
Junpei Yamamoto
Katsuma Matsui
Kazutaka Nagatomo
Kei Sudo
Keiichi Masuya
Koichi Watashi
Koji Yoshida
Masaki Ohuchi
Naoko Iwata
Naoko Nakamura
Noriyo Nagata
Nozomi Shiwa
Tadaki Suzuki
Takayuki Nagasawa
Tatsuya Niimi
Yoshiaki Masuda
Yoshiaki Shimada
Original Assignee
Japan As Represented By The Director General Of Nat Institute Of Infectious Diseases
Peptiaid Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan As Represented By The Director General Of Nat Institute Of Infectious Diseases, Peptiaid Inc filed Critical Japan As Represented By The Director General Of Nat Institute Of Infectious Diseases
Publication of BR112023019228A2 publication Critical patent/BR112023019228A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002—Coronaviridae
    • C07K16/1003—Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2 or Covid-19]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

peptídeo e composição contendo o peptídeo. a presente invenção refere-se a um peptídeo e a uma composição contendo o peptídeo. o peptídeo da presente invenção compreende a seguinte sequência de aminoácidos: mea-mef-s-cha-y-s-y-y-r-r-cha-c (seq id no: 2) ou uma sequência de aminoácidos tendo uma substituição, adição, deleção ou inserção em uma quantidade de 1 a 10 resíduos aminoacídicos selecionados do grupo que consiste nos resíduos aminoacídicos nas posições 1, 2, 3, 4, 5, 6, 7, 8, 9 e 10 na sequência de aminoácidos acima.
BR112023019228A 2021-03-22 2022-03-22 Peptídeo e composição contendo o peptídeo BR112023019228A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021047773 2021-03-22
JP2021192510 2021-11-26
PCT/JP2022/013180 WO2022202816A1 (ja) 2021-03-22 2022-03-22 ペプチド及びペプチドを含む組成物

Publications (1)

Publication Number Publication Date
BR112023019228A2 true BR112023019228A2 (pt) 2023-11-28

Family

ID=83395638

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023019228A BR112023019228A2 (pt) 2021-03-22 2022-03-22 Peptídeo e composição contendo o peptídeo

Country Status (9)

Country Link
EP (1) EP4317174A1 (pt)
JP (1) JPWO2022202816A1 (pt)
KR (1) KR20230170918A (pt)
AU (1) AU2022242421A1 (pt)
BR (1) BR112023019228A2 (pt)
CA (1) CA3214455A1 (pt)
IL (1) IL307225A (pt)
TW (1) TW202304947A (pt)
WO (1) WO2022202816A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023048151A1 (ja) * 2021-09-22 2023-03-30 塩野義製薬株式会社 ウイルス増殖阻害活性を有する環状ペプチド
WO2023192873A1 (en) * 2022-03-28 2023-10-05 Bristol-Myers Squibb Company Macrocyclic immunomodulators
CN116445523B (zh) * 2023-04-10 2024-05-07 西北农林科技大学 一种小麦抗逆性基因TaBSL3与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525491A (en) 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
BR0116024A (pt) 2000-12-07 2005-12-13 Lilly Co Eli Proteìna de fusão heteróloga e uso da mesma
CA2598360C (en) * 2005-02-17 2016-12-20 Polyphor Ltd. Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
EP1964916B1 (en) 2005-12-06 2012-08-01 The University of Tokyo Multi-purpose acylation catalayst and use thereof
JP5818237B2 (ja) 2010-09-09 2015-11-18 国立大学法人 東京大学 Ｎ−メチルアミノ酸およびその他の特殊アミノ酸を含む特殊ペプチド化合物ライブラリーの翻訳構築と活性種探索法
JPWO2014119600A1 (ja) 2013-01-30 2017-01-26 ペプチドリーム株式会社 ＦｌｅｘｉｂｌｅＤｉｓｐｌａｙ法
CN111349150B (zh) * 2020-03-24 2021-02-09 北京中科微盾生物科技有限责任公司 一种抑制新型冠状病毒的多肽及其用途
CN111471088B (zh) * 2020-04-21 2021-02-09 北京中科微盾生物科技有限责任公司 一种抑制sars-cov-2感染的多肽、组合物及其用途
CN111732637B (zh) * 2020-05-25 2022-03-01 上海交通大学 抑制新型冠状病毒SARS-CoV-2感染宿主细胞的多肽及其应用
CN111499692B (zh) * 2020-06-16 2020-12-04 国家纳米科学中心 靶向新型冠状病毒covid-19的多肽及其应用

Also Published As

Publication number Publication date
CA3214455A1 (en) 2022-09-29
AU2022242421A2 (en) 2023-11-16
TW202304947A (zh) 2023-02-01
JPWO2022202816A1 (pt) 2022-09-29
WO2022202816A1 (ja) 2022-09-29
IL307225A (en) 2023-11-01
EP4317174A1 (en) 2024-02-07
KR20230170918A (ko) 2023-12-19
AU2022242421A1 (en) 2023-11-02

Similar Documents

Publication Publication Date Title
BR112023019228A2 (pt) Peptídeo e composição contendo o peptídeo
NO20092774L (no) HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
Lomonte et al. Two color morphs of the pelagic yellow-bellied sea snake, Pelamis platura, from different locations of Costa Rica: Snake venomics, toxicity, and neutralization by antivenom
BR112021017603A2 (pt) Vírus adenoassociado (aav) mutante tendo propriedade de direcionamento para o cérebro
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
Baxter et al. Radiocarbon dating of mortars
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
DE69027989T2 (de) Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON
BR0211200A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
BR112021021912A2 (pt) Nova nuclease omni-50 crispr
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
BRPI0507186A (pt) composição, métodos e usos para uma nova famìlia de peptìdeos
CY1108570T1 (el) Gd3-μιμητικα πεπτιδια
ATE387205T1 (de) Zusammensetzungen zur behandlung von durch c. difficile toxin b verursachten durchfallerkrankungen (cdad)
BR9814760A (pt) Proteìna anticongelamento, sequência de ácido nucléico, e, produto alimentìcio.
Heintz et al. Use of bimanyl actin derivative (TMB‐actin) for studying complexation of β‐thymosins: Inhibition of actin polymerization by thymosin β9
NZ614557A (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
BR112023022398A2 (pt) Composições e método para vacinas peptídicas otimizadas usando otimização de resíduos
BR112022003760A2 (pt) Análogos de compstatina e seus usos médicos
DK0918865T3 (da) Immunologisk aktive proteiner af Borrelia burgdorferi, derfor kodende nukleinsyrer samt deres anvendelse i testkits og som vacciner
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten
Hase et al. Amino acid sequence of Chromatium vinosum ferredoxin: revisions
BR112023016442A2 (pt) Composições de soluções aquosas para aumentar a estabilidade de proteínas diméricas modificadas
KR960703432A (ko) 신경퇴행성 질환의 치료를 위한 제약학적 조성물 및 이들의 사용방법(pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases)
CN101969960A (zh) 使用γ抑制剂化合物减轻疼痛的方法